Register Now

Faculty

Steven H. Swerdlow [M.D.]

  • Titles : Director of the Division of Hematopathology
  • Affiliations : University of Pittsburgh Health System

Dr. Steven H. Swerdlow received his BA from Brandeis University, his MD from Harvard Medical School, his residency training in pathology at Beth Israel Hospital in Boston, and Fellowship training in Hematopathology at Vanderbilt University Medical Center and at St. Bartholomew’s Hospital in London. He is Professor of Pathology and Director of both the Division of Hematopathology and the Hematopathology Fellowship Program at the University of Pittsburgh School of Medicine. Dr. Swerdlow has published 105 original articles in his area of research, co-authored two medical texts: Pediatric Hematology and Biopsy Interpretation of Lymph Nodes and written numerous monographs, chapters and invited reviews in hematopathology. He is the past-President of the Society for Hematopathology, serves on the editorial board of two major pathology journals and is on the steering committee for the revised WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. Click here for additional info.

  • National Board of Medical Examiners, 1976
  • American Board of Pathology:
  • Anatomic & Clinical Pathology 1979 
  • Recertification (2013-2023), 2013 
  • Maintenance of Certification Participant (Diplomate) 2012-Present

  • Listed in America's Top Doctors (US News & World Report top 1% in specialty) 2001-2013
  • Outstanding Teaching in Clinical Pathology Resident Award, 1994, 2001, 2009
  • Trustee, American Board of Pathology
  • Elected Member, International Lymphoma Study Group

  • Pongpruttipan, T., Sukpanichnant, S., Assanasen, T., Wannakrairot, P., Boonsakan, P., Kanoksil, W., Kayasut, K., Mitarnun, W., Khuhapinant, A., Bunworasate, U., Puavilai, T., Bedavanija, A., Garcia-Herrera, A., Campo, E., Cook, J., Choi, J., Swerdlow, S.H. Extranodal NK/T-cell Lymphomas, Nasal Type, includes cases of natural killer cell, αβ, γδ, and αβ/γδ T-cell Origin: a comprehensive clinicopathologic and phenotypic study. Am J Surg Pathol, 2012, 36(4) 481-499.
  • Bieliauskas, S., Tubbs, R.R., Bacon, C., Eshoa, C., Foucar, K., Gibson, S., Kroft, S., Sohani, A., Swerdlow, S.H., Cook, J.R. Gamma Heavy Chain Disease: Defining the Spectrum of Associated Lumphoproliferative Disorders Through Analysis of 13 Cases. Am J Surg Pathol, 2012, 36(4)534-543.
  • Aggarwal, N., Swerdlow, S.H., Kelly, L.M., Ogilvie, J.B., Sathanoori, M., Nikiforova, M.N., Nikiforov, Y.E. Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas. Modern Pathology, 2012, 25, 1203-1211.
  • Carvajal-Cuenca, A., Sua, L.F., Silva, N.M., Pittaluga, S., Royo, C., Song, J., Sargent, R.L., Espinet, B., Climent, F., Jacobs, S.A., Delabie, J., Naresh, K.N., Bagg, A., Brousset, P., Warnke, R.A., Serrano, S., Harris, N.L., Swerdlow, S.H., Jaffe, E.S., and Campo, E. In-situ Mantle Cell Lymphoma: Clinical Implications of an incidental finding with indolent clinical behavior. Haematologica, 2012, 97(2):270-278.
  • Craig, F., Monaghan, S., Surti, U., Swerdlow, S.H. ZAP-70 and Bcl-2 Expression in B Lymphoblastic Leukemia Cells and Hematogones, Cytometry: Part B - Clinical Cytometry, 2012, Vol 82B, Issue 2, 85-92.
  • Gradowski, J.F., Sargent, R.L., Craig, F.E., Cieply, K., Fuhrer, K., Sherer, C., Swerdlow, S.H. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Cyclin D1 Positive Proliferation Centers Do Not Have CCND1 Translocations or Gains and Lack SOX11 Expression. Am J Clin Pathology, 2012, 138:132-139. [Selected for CME activity.]
  • Royo C, Navarro A, Clot G, Salaverria I, Giné E, Jares P, Colomer D, Wiestner A, Wilson WH, Vegliante MC, Fernandez V, Hartmann EM, Trim N, Erber WN, Swerdlow SH, Klapper W, Dyer MJ, Vargas-Pabón M, Ott G, Rosenwald A, Siebert R, López-Guillermo A, Campo E, Beà S. Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease (letter to editor). Leukemia, 2012 26:1895-1898.

  • Diagnosing Lymphomas and Leukemias -- What the Surgical Pathologist Needs to Know
  • Diagnosing Lymphomas and Leukemias: Challenges for the Surgical Pathologist
  • For the Practicing Surgical Pathologist: Hematopathology from A to Z
  • Practical Hematopathology for the Surgical Pathologist – A Survival Guide for 2016

Past Lectures

  • A Multiparameter Approach Saves the Day: Case Studies with B-Cell Neoplasms (06/30/2016)
  • Diagnostic Decision-Making with Blastic/Blastoid and Large B-Cell Proliferations (06/28/2016)
  • Dealing with Small B-Cell Neoplasms of Lymph Nodes and Spleen (06/28/2016)
  • Approaching Diagnostic Lymph Node (and Related Tissue) Biopsies: The Tools of Our Trade (06/27/2016)
  • Lymphoma Diagnosis and Classification: A Revised WHO is on its Way (06/27/2016)
  • Recapping the B-Cell Neoplasms: A Case-Based Exercise (06/19/2014)
  • Dealing with the Aggressive B-Cell Lymphomas and Their Differential Diagnosis (06/17/2014)
  • Small B-Cell Lymphoid Neoplasms of Lymph Nodes & Spleen (06/17/2014)
  • Lymphoma Diagnosis and Classification in 2014 (06/16/2014)
  • Our Current Diagnostic Armamentarium: A Practical Approach to Diagnosing Lymphoid Proliferations (06/16/2014)
  • Diagnostic Challenges: B-Cell Lymphomas (06/27/2012)
  • Spectrum of Nodal and Splenic Small B-Cell Lymphomas (06/26/2012)
  • Aggressive B-Cell Lymphomas and Their Mimics (06/26/2012)
  • A Multiparameter Pragmatic Approach to Diagnosing, Classifying Lymphomas in 2012, Part 2 (06/25/2012)
  • A Multiparameter Pragmatic Approach to Diagnosing Lymphomas in 2012, Part 1 (06/25/2012)
  • Case Studies in B-Cell Lymphomas (10/21/2010)
  • Nodal and Splenic Small B-Cell Lymphomas (10/19/2010)
  • Aggressive B-Cell Lymphomas and their Differential Diagnosis (10/19/2010)
  • Lymphoma Classification: An Update and Overview (10/18/2010)
  • Approach to the Diagnosis of Lymphoid Proliferations and Our Diagnostic Armamentarium (10/18/2010)

X


Welcome to Scientific Symposiums International

We hope you find the new website to have all the valuable content and information you need.

Please let us know if you have any feedback!

Enter your email to receive the latest news, updates and promotions for our upcoming courses!

Continue